AUD 0.06
(-1.69%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 9.82 Million AUD | 0.36% |
2023 | 9.79 Million AUD | 8.67% |
2022 | 9 Million AUD | 36.83% |
2021 | 6.58 Million AUD | 363.83% |
2020 | 1.41 Million AUD | 0.18% |
2019 | 1.41 Million AUD | 83.24% |
2018 | 773.32 Thousand AUD | -98.58% |
2017 | 54.55 Million NZD | 138.91% |
2016 | 22.83 Million NZD | 0.0% |
2015 | - NZD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 2.65 Million AUD | 0.0% |
2024 Q3 | 2.65 Million AUD | 40.84% |
2024 FY | 4.47 Million AUD | -54.34% |
2024 Q1 | 2.33 Million AUD | 0.96% |
2024 Q2 | 1.88 Million AUD | -19.34% |
2023 Q1 | 2.66 Million AUD | 65.4% |
2023 FY | 9.79 Million AUD | 8.67% |
2023 Q2 | 1.7 Million AUD | -35.96% |
2023 Q4 | 2.31 Million AUD | -6.15% |
2023 Q3 | 2.46 Million AUD | 44.29% |
2022 FY | 9 Million AUD | 36.83% |
2022 Q4 | 1.61 Million AUD | 0.0% |
2021 FY | 6.58 Million AUD | 363.83% |
2020 FY | 1.41 Million AUD | 0.18% |
2019 FY | 1.41 Million AUD | 83.24% |
2018 FY | 773.32 Thousand AUD | -98.58% |
2017 FY | 54.55 Million NZD | 138.91% |
2016 FY | 22.83 Million NZD | 0.0% |
2016 Q4 | 13.63 Million NZD | 0.0% |
2016 Q3 | 13.63 Million NZD | 0.0% |
2016 Q2 | 13.63 Million NZD | 138.91% |
2016 Q1 | 5.7 Million NZD | 0.0% |
2015 Q2 | 5.7 Million NZD | 0.0% |
2015 Q4 | 5.7 Million NZD | 0.0% |
2015 Q3 | 5.7 Million NZD | 0.0% |
2015 FY | - NZD | 0.0% |
2015 Q1 | - NZD | 0.0% |
2014 Q2 | - NZD | 0.0% |
2014 Q4 | - NZD | 0.0% |
2014 Q3 | - NZD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 68.791% |
Adherium Limited | 267.7 Thousand AUD | -3570.455% |
Aroa Biosurgery Limited | 66.09 Million AUD | 85.135% |
Atomo Diagnostics Limited | 1.6 Million AUD | -511.824% |
Anteris Technologies Ltd | 69.14 Million AUD | 85.79% |
CardieX Limited | 16.64 Million AUD | 40.982% |
Compumedics Limited | 26.88 Million AUD | 63.445% |
Cochlear Limited | 1.17 Billion AUD | 99.163% |
CleanSpace Holdings Limited | 11.35 Million AUD | 13.499% |
Cyclopharm Limited | 13.38 Million AUD | 26.567% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 23.436% |
Nova Eye Medical Limited | 23.99 Million AUD | 59.042% |
HeraMED Limited | 6.78 Million AUD | -44.862% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 980.586% |
ImpediMed Limited | 28.04 Million AUD | 64.959% |
InhaleRx Limited | 2.59 Million AUD | -279.301% |
LBT Innovations Limited | 1.1 Million AUD | -787.617% |
Micro-X Limited | 18.76 Million AUD | 47.634% |
Neurotech International Limited | 8.75 Million AUD | -12.241% |
OncoSil Medical Limited | 12.03 Million AUD | 18.388% |
PolyNovo Limited | 34.92 Million AUD | 71.863% |
Respiri Limited | 8.03 Million AUD | -22.291% |
SomnoMed Limited | 58.97 Million AUD | 83.338% |
Universal Biosensors, Inc. | 20 Million AUD | 50.871% |
Uscom Limited | 5.52 Million AUD | -78.004% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -1.996% |